PMCPA Case Library

Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.

1,930
Cases
291
Companies
154
Clauses
6
Code Versions

or browse all 154 ABPI clause guides ↗

Case Library Membership

Filter by Company & ABPI Clause

Search free — but unlock advanced filters to find every case involving a specific company or clause.

Filter 1,930+ cases by any of 291 companies
Filter by any of 154 ABPI Code clauses
Filter by Code version (2016, 2019, 2021…)
Full-text keyword search across all cases
Cancel any time

Already a member? Sign in →

Case Library Membership

Best value
£249 /year Save £99

inc. VAT

£29 /month

inc. VAT · cancel any time

Unlock Full Access →

Secure payment via Stripe


Need access for your team?

Company licences available for compliance teams, medical affairs, and training programmes.

Get a team quote →

1,930 cases found

08
Mar 2026
2008 Code Reckitt Benckiser Healthcare

AUTH/2114/4/08: Pharmacist complaint about “Reflux super-suppressant” claim for Gaviscon Advance (BMJ advertisement)

A pharmacist challenged the strapline “Reflux super-suppressant” in a BMJ advert for Gaviscon Advance. The Panel found it implied unsubstantiated general superiority…

08
Mar 2026
2008 Code Reckitt Benckiser Clause 9

AUTH/2116/4/08: General practitioner v Reckitt Benckiser Healthcare – unsolicited promotional email (Gaviscon Advance)

A GP complained that he continued to receive promotional emails after opting out. A third-party agency failed to remove his details, and…

08
Mar 2026
2008 Code Boehringer Ingelheim

Boehringer Ingelheim press release about Pradaxa appeared to come from Lifeblood without consent

A subcontracted media advisor altered and distributed an unauthorised Pradaxa press release that appeared to be from Lifeblood and misused quotations. The…

08
Mar 2026
2008 Code Merz Pharma UK Clause 7.2

Allergan v Merz Pharma UK Ltd: Xeomin promotion claims on complexing proteins and dosing ratio

Allergan challenged Xeomin promotional claims in a BMJ ad, leavepiece and conference stand panels. The Panel ruled some claims misleading about complexing…

08
Mar 2026
2008 Code Bayer Schering Pharma Clause 2

AUTH/2122/5/08: Anonymous ex-employee v Bayer Schering Pharma – Nebido advertisement (no breach)

An ex-employee alleged a Nebido BMJ ad implied men would become attractive to younger women (unlicensed). The Panel found the imagery reflected…

08
Mar 2026
2008 Code Roche Products

AUTH/2124/5/08: Anonymous consultant rheumatologist v Roche – MabThera symposium (celebrity co-chair)

Complaint alleged Roche used a TV newsreader as co-chair to attract delegates, provided hospitality to an unqualified lay person, and promoted MabThera…

08
Mar 2026
2008 Code Janssen-Cilag

Janssen-Cilag Lyrinel XL ad: illustration found to misrepresent study discontinuations and recommendation rates

A pharmacist challenged a Lyrinel XL ad’s “Gets our vote” imagery. The Panel found the illustration exaggerated satisfaction by ignoring discontinuations and…

08
Mar 2026
Pfizer

AUTH/2058/10/07: Chief Pharmacist v Pfizer – Champix advertisement in Health Service Journal

A primary care trust chief pharmacist questioned whether a Champix ad in the Health Service Journal could be seen by non-health professionals.…

08
Mar 2026
Teva UK Clause 7.2 Clause 7.4 Clause 9.5

Teva UK Ltd: Guidelines in Practice insert on switching to CFC-free beclometasone inhalers (Qvar) found misleading and promotional

A GP challenged a Teva-supported insert distributed with Guidelines in Practice. The Panel found it was effectively a paid promotional insert for…

08
Mar 2026
Teva UK Clause 9 Clause 15

Teva: Representative call rates and bonus-linked activity targets (AUTH/2065/11/07 & AUTH/2066/11/07)

Two anonymous Teva representatives alleged excessive call-rate targets and bonus-linked activity created indirect pressure to breach the Code. The Panel found briefing/instructions…

08
Mar 2026
Takeda UK Clause 7

AUTH/2071/11/07: GP v Takeda – Competact/Actos leavepiece and mixed use of relative vs absolute risk

A GP challenged a Takeda promotional leavepiece for pioglitazone that presented benefits as relative risk reduction but harms as absolute risk. The…

08
Mar 2026
2008 Code Pfizer Clause 1.2 Clause 4.1

Pfizer letter requesting addition of Ecalta and Celsentri to hospital e-prescribing system ruled promotional without prescribing information

A hospital pharmacist complained about a Pfizer-authorised letter asking hospitals to add Ecalta and Celsentri to electronic prescribing/dispensing systems. The Panel ruled…

08
Mar 2026
2008 Code Gamble Pharmaceuticals UK Procter

Roche and GlaxoSmithKline v Sanofi-Aventis and Procter & Gamble (Actonel exhibition panel): no breach

Competitors alleged an Actonel exhibition panel used out-of-licence safety data and downplayed SPC GI warnings. The Panel found the panel clearly related…

08
Mar 2026
2008 Code Teva UK Clause 10

Teva found in breach for disguised promotion via sponsored “Guidelines in Practice” supplement (AUTH/2081/1/08)

A PCT pharmacist alleged a Teva-supported supplement about switching to CFC-free beclometasone inhalers was disguised promotion for Qvar. The Panel ruled Teva’s…

08
Mar 2026
Recordati Pharmaceuticals Clause 9.1 Clause 9.5

Recordati: Tradorec XL ‘Dear Dispensary Manager’ letter and MHRA reference

A hospital pharmacy manager complained about a Recordati letter for Tradorec XL citing MHRA advice on brand prescribing and substitution. The Panel…

1123124125126127128129

Ask questions about any PMCPA case

Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free